In SURMOUNT-3, 600 participants are randomized to receive either tirzepatide at the maximally tolerated dose or placebo following a structured intensive 12-week lifestyle intervention
A doctor should assess BMI, medical history, blood sugar, side effects, and treatment goals before recommending an option
HS-20094, independently developed by Hansoh Pharma, is a novel Dual GIP and GLP-1 Receptor Agonist
The longer a patient takes Metformin, the better it has been shown to push back diseases of aging, according to several research studies in both humans and lab animals (see our Metformin Science section)
For the full picture of what to expect and how a provider keeps them minimal, see our guide on the common side effects of Ozempic and other GLP-1 medications and how a provider helps you manage them safely